MyAverix Finance
HK · Healthcare
Sino Biopharmaceutical Ltd (1177)
Biotechnology
Sino Biopharmaceutical Ltd (1177) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $94.19B, P/E ratio is 35.20, net margin is 7.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1177
Sino Biopharmaceutical Ltd (1177) — FAQ
What is Sino Biopharmaceutical Ltd's market cap?
Sino Biopharmaceutical Ltd (1177) has a reported market cap of $94.19B (data as of 2026-05-21).
What is 1177's P/E ratio?
The price-to-earnings (P/E) ratio for Sino Biopharmaceutical Ltd (1177) is 35.20 (data as of 2026-05-21).
Does Sino Biopharmaceutical Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sino Biopharmaceutical Ltd (1177). Check the MyAverix Finance app for the latest dividend data.
What sector is Sino Biopharmaceutical Ltd in?
Sino Biopharmaceutical Ltd (1177) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1177 listed on?
1177 is listed on HK.
What is Sino Biopharmaceutical Ltd's net margin?
Sino Biopharmaceutical Ltd (1177) reports a net margin of 7.4% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.